Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
Add more filters










Publication year range
1.
J Steroid Biochem Mol Biol ; 172: 188-197, 2017 09.
Article in English | MEDLINE | ID: mdl-28645527

ABSTRACT

17beta-hydroxysteroid dehydrogenase type 7 (17ß-HSD7) promotes breast cancer cell growth via dual-catalytic activity by modulating estradiol and DHT. Here, we clarified the expression pattern of 17ß-HSD7 in postmenopausal luminal A type breast cancer with The Cancer Genome Atlas (TCGA) cohort. The impact of 17ß-HSD7 inhibition on the proteome of MCF-7 cells was investigated and on cell apoptosis was revealed. MCF-7 cells were treated with an efficient inhibitor of 17ß-HSD7 (INH7) or with vehicle, and a differential proteomics study was performed using two-dimensional (2D) gel electrophoresis followed by mass spectrometry and ingenuity pathway analysis (IPA). Cell apoptosis was analyzed by flow cytometry, followed by reverse transcription quantitative real-time PCR (RT-qPCR) and Western blot to investigate the expression of apoptosis-related genes. Our data showed 17ß-HSD7 is amplified in primary and progressive breast cancer, inhibition of 17ß-HSD7 in MCF-7 cells modulated 104 proteins primarily involved in cell death/survival, cell growth and DNA processing. The expression of 78kDa glucose-regulated protein (GRP78) and anti-apoptosis factor Bcl-2 were significantly suppressed via 17ß-HSD7 inhibition with INH7, consequently induced MCF-7 cell apoptosis. However, INH7 treatment of T47D, another widely used epithelial ER+ breast cancer cell line, led to an up-regulation of GRP78 expression, resulting in a limited increase in apoptosis. These results suggest cell-specific effects of INH7 in the breast cancer, which is interesting for further study. An combinatory effect on apoptosis by INH7 and Letrozole (aromatase inhibitor) was further demonstrated in MCF-7. Down-regulation of GRP78 via 17ß-HSD7 inhibition enhances cell apoptosis in response to Letrozole. This study highlights GRP78 as a key regulator related to 17ß-HSD7 inhibition and effect. Taken together, results from the present study suggest a hypothesis that inhibition of 17ß-HSD7 would be a complementary strategy to Letrozole by suppression of GRP78 in ER+ breast cancer. However, from a research perspective, further studies have to be carried out with more breast cancer cell lines as well as in vivo model to assess the efficacy of inhibitor combination.


Subject(s)
17-Hydroxysteroid Dehydrogenases/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Enzyme Inhibitors/pharmacology , Epithelial Cells/drug effects , Gene Expression Regulation, Neoplastic , Receptors, G-Protein-Coupled/antagonists & inhibitors , 17-Hydroxysteroid Dehydrogenases/genetics , 17-Hydroxysteroid Dehydrogenases/metabolism , Apoptosis/drug effects , Apoptosis/genetics , Aromatase Inhibitors/pharmacology , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Drug Synergism , Endoplasmic Reticulum Chaperone BiP , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Gene Expression Profiling , Heat-Shock Proteins , Humans , Letrozole , Molecular Sequence Annotation , Nitriles/pharmacology , Organ Specificity , Postmenopause , Protein Interaction Mapping , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Signal Transduction , Triazoles/pharmacology
2.
J Clin Endocrinol Metab ; 101(12): 4752-4763, 2016 12.
Article in English | MEDLINE | ID: mdl-27726474

ABSTRACT

CONTEXT: Angiogenesis is required for ectopic endometrial tissue growth. Our previous studies showed that prostaglandin F2α (PGF2α) biosynthetic enzymes and receptor were markedly elevated in endometriotic lesions and that PGF2α is a potent angiogenic factor in endothelial cells. OBJECTIVE: We sought to determine whether or not the F-prostanoid receptor modulates angiogenesis in ectopic stromal cells. DESIGN: Release of angiogenic factors by ectopic endometrial stromal cell primary cultures stimulated with PGF2αand exposed to agents that target PGF2α signaling was assessed. SETTING: The study was conducted in an immunology laboratory at the Centre Hospitalier Universitaire (Québec City) medical research center. PATIENTS: Women found to have peritoneal endometriosis during laparoscopy were included in this study. MAIN OUTCOME MEASURE(S): Prostaglandin E2, PGF2α, vascular endothelial cell growth factor, and CXC chemokine ligand 8 mRNA and protein; FP prostanoid receptor expression. RESULTS: PGF2α markedly up-regulated prostaglandin E2, CXC chemokine ligand 8 and vascular endothelial cell growth factor secretion in endometriotic cells. This effect was suppressed in the presence of a specific F-prostanoid antagonist (AL8810) and its signaling pathway was dependent on F-prostanoid receptor variant. PGF2α can exert its proliferative and angiogenic activities either directly by stimulating endothelial cell proliferation, migration and angiogenesis through F-prostanoid receptor, or indirectly, by stimulating endometriotic stromal cells to produce potent angiogenic factors through either receptor variant. CONCLUSION: These results show for the first time that PGF2α exerts an angiogenic effect on ectopic stromal cells, inducing the secretion of major angiogenic factors via different F-prostanoid signaling pathways. This study suggests a new interpretation of the mechanism underlying endometriosis development involving PGF2α in endometriosis-associated angio-inflammatory changes.


Subject(s)
Angiogenesis Inducing Agents/metabolism , Dinoprost/metabolism , Endometriosis/metabolism , Peritoneal Diseases/metabolism , Receptors, Prostaglandin/metabolism , Signal Transduction , Adult , Angiogenesis Inducing Agents/pharmacology , Cells, Cultured , Dinoprost/pharmacology , Female , Humans , Stromal Cells , Vascular Endothelial Growth Factor A/metabolism
3.
J Vis Exp ; (114)2016 08 18.
Article in English | MEDLINE | ID: mdl-27585303

ABSTRACT

Mammalian cell culture in monolayers is widely used to study various physiological and molecular processes. However, this approach to study growing cells often generates unwanted artifacts. Therefore, cell culture in a three-dimensional (3D) environment, often using extracellular matrix components, emerged as an interesting alternative due to its close similarity to the native in vivo tissue or organ. We developed a 3D cell culture system using two compartments, namely (i) a central compartment containing cancer cells embedded in a collagen gel acting as a pseudo-primary macrospherical tumor and (ii) a peripheral cell-free compartment made of a fibrin gel, i.e. an extracellular matrix component different from that used in the center, in which cancer cells can migrate (invasion front) and/or form microspherical tumors representing secondary or satellite tumors. The formation of satellite tumors in the peripheral compartment is remarkably correlated to the known aggressiveness or metastatic origin of the native tumor cells, which makes this 3D culture system unique. This cell culture approach might be considered to assess cancer cell invasiveness and motility, cell-extracellular matrix interactions and as a method to evaluate anti-cancer drug properties.


Subject(s)
Cell Culture Techniques/methods , Cell Movement/physiology , Extracellular Matrix , Neoplasm Invasiveness , Animals , Collagen , Fibrin , Humans , Imaging, Three-Dimensional , Neoplasms
4.
Mol Cell Endocrinol ; 412: 339-48, 2015 Sep 05.
Article in English | MEDLINE | ID: mdl-26044867

ABSTRACT

Our objectives were to investigate the interactions between mammary cancer epithelial cells (MCF-7) and stromal cells (Hs-578Bst) at the level of the expression and inhibition of steroidogenesis enzymes by using monolayer and three dimensional co-culture models. Expressions of steroidogenesis enzymes and E2/DHT conversions in co-cultured MCF-7 and Hs-578Bst cells as well as the effects of aromatase inhibitor combined to steroid sulfatase (STS) and 17ß-hydroxysteroid dehydrogenases (17ßHSDs) inhibitors were evaluated. 17ß-HSD type 7 was mostly modulated in MCF-7 cells whereas aromatase was mostly regulated in Hs578Bst cells thereby increasing E2 conversion and MCF-7 cell growth. A combination of inhibitors toward aromatase, STS and 17ß-HSD7, was found to be the most significant treatment in decreasing E2 and elevating DHT thus inhibiting MCF-7 cell proliferation and spheroid-like cancer cell aggregation in collagen gel. The interactions between those cells modulated E2 formation in paracrine/intracrine manners by synergistically regulating aromatase, 17ß-HSD7 and STS. Among tumor-associated cells, stromal fibroblasts may participate in intratumoral E2 deposition; therefore promoting breast cancer cell growth.


Subject(s)
17-Hydroxysteroid Dehydrogenases/metabolism , Aromatase/metabolism , Epithelial Cells/enzymology , Fibroblasts/enzymology , Steryl-Sulfatase/metabolism , 17-Hydroxysteroid Dehydrogenases/genetics , Aromatase/genetics , Biosynthetic Pathways , Coculture Techniques , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , MCF-7 Cells , Mammary Glands, Human/pathology , Steryl-Sulfatase/genetics
5.
J Mol Cell Biol ; 7(6): 568-79, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25966904

ABSTRACT

17ß-hydroxysteroid dehydrogenase (17ß-HSD) type 1 is known as a critical target to block the final step of estrogen production in estrogen-dependent breast cancer. Recent confirmation of the role of dyhydroxytestosterone (DHT) in counteracting estrogen-induced cell growth prompted us to study the reductive 17ß-HSD type 7 (17ß-HSD7), which activates estrone while markedly inactivating DHT. The role of DHT in breast cancer cell proliferation is demonstrated by its independent suppression of cell growth in the presence of a physiological concentration of estradiol (E2). Moreover, an integral analysis of a large number of clinical samples in Oncomine datasets demonstrated the overexpression of 17ß-HSD7 in breast carcinoma. Inhibition of 17ß-HSD7 in breast cancer cells resulted in a lower level of E2 and a higher level of DHT, successively induced regulation of cyclinD1, p21, Bcl-2, and Bik, consequently arrested cell cycle in the G(0)/G(1) phase, and triggered apoptosis and auto-downregulation feedback of the enzyme. Such inhibition led to significant shrinkage of xenograft tumors with decreased cancer cell density and reduced 17ß-HSD7 expression. Decreased plasma E2 and elevated plasma DHT levels were also found. Thus, the dual functional 17ß-HSD7 is proposed as a novel target for estrogen-dependent breast cancer by regulating the balance of E2 and DHT. This demonstrates a conceptual advance on the general belief that the major role of this enzyme is in cholesterol metabolism.


Subject(s)
17-Hydroxysteroid Dehydrogenases/metabolism , Androgens/metabolism , Breast Neoplasms/enzymology , Dihydrotestosterone/metabolism , Estradiol/metabolism , Estrogens/metabolism , 17-Hydroxysteroid Dehydrogenases/antagonists & inhibitors , 17-Hydroxysteroid Dehydrogenases/genetics , Androgens/blood , Androgens/pharmacology , Apoptosis , Apoptosis Regulatory Proteins/metabolism , Breast Neoplasms/metabolism , Cell Cycle Checkpoints , Cell Proliferation/drug effects , Cholesterol/metabolism , Cyclin D1/metabolism , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Dihydrotestosterone/blood , Dihydrotestosterone/pharmacology , Estradiol/blood , Estradiol Dehydrogenases/chemistry , Estrogens/blood , Estrone/metabolism , Female , G1 Phase , Humans , MCF-7 Cells , Membrane Proteins/metabolism , Mitochondrial Proteins , Multifunctional Enzymes/antagonists & inhibitors , Multifunctional Enzymes/chemistry , Multifunctional Enzymes/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Resting Phase, Cell Cycle
6.
Biomaterials ; 54: 126-35, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25907046

ABSTRACT

Copper is becoming recognised as a key cation in a variety of biological processes. Copper chelation has been studied as a potential anti-angiogenic strategy for arresting tumour growth. Conversely the delivery of copper ions and complexes in vivo can elicit a pro-angiogenic effect. Previously we unexpectedly found that copper-stimulated intraperitoneal angiogenesis was accompanied by collagen deposition. Here, in hard tissue, not only was healing accelerated by copper, but again enhanced deposition of collagen was detected at 2 weeks. Experiments with reconstituted collagen showed that addition of copper ions post-fibrillogenesis rendered plastically-compressed gels resistant to collagenases, enhanced their mechanical properties and increased the denaturation temperature of the protein. Unexpectedly, this apparently interfibrillar crosslinking was not affected by addition of glucose or ascorbic acid, which are required for crosslinking by advanced glycation end products (AGEs). Fibroblasts cultured on copper-crosslinked gels did not proliferate, whereas those cultured with an equivalent quantity of copper on either tissue culture plastic or collagen showed no effect compared with controls. Although non-proliferative, fibroblasts grown on copper-cross-linked collagen could migrate, remained metabolically active for at least 14 days and displayed a 6-fold increase in Mmps 1 and 3 mRNA expression compared with copper-free controls. The ability of copper ions to crosslink collagen fibrils during densification and independently of AGEs or Fenton type reactions is previously unreported. The effect on MMP susceptibility of collagen and the dramatic change in cell behaviour on this crosslinked ECM may contribute to shedding some light on unexplained phenomena as the apparent benefit of copper complexation in fibrotic disorders or the enhanced collagen deposition in response to localised copper delivery.


Subject(s)
Copper/metabolism , Extracellular Matrix/metabolism , Fibrillar Collagens/metabolism , Fibroblasts/cytology , Fibroblasts/physiology , Matrix Metalloproteinases/metabolism , Cell Differentiation/physiology , Cell Proliferation/physiology , Cells, Cultured , Copper/chemistry , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/metabolism , Extracellular Matrix/chemistry , Fibrillar Collagens/chemistry , Humans
7.
J Artif Organs ; 15(3): 250-65, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22610313

ABSTRACT

The use of hollow-fiber membrane bioreactors (HFMBs) has been proposed for three-dimensional bone tissue growth at the clinical scale. However, to achieve an efficient HFMB design, the relationship between cell growth and environmental conditions must be determined. Therefore, in this work, a dynamic double-porous media model was developed to determine nutrient-dependent cell growth for bone tissue formation in a HFMB. The whole hollow-fiber scaffold within the bioreactor was treated as a porous domain in this model. The domain consisted of two interpenetrating porous regions, including a porous lumen region available for fluid flow and a porous extracapillary space filled with a collagen gel that contained adherent cells for promoting long-term growth into tissue-like mass. The governing equations were solved numerically and the model was validated using previously published experimental results. The contributions of several bioreactor design and process parameters to the performance of the bioreactor were studied. The results demonstrated that the process and design parameters of the HFMB significantly affect nutrient transport and thus cell behavior over a long period of culture. The approach presented here can be applied to any cell type and used to develop tissue engineering hollow-fiber scaffolds.


Subject(s)
Bone Marrow Cells/cytology , Bone Transplantation/methods , Models, Theoretical , Osteogenesis/physiology , Tissue Engineering/methods , Bioreactors , Cell Culture Techniques , Cell Proliferation , Cells, Cultured , Computer Simulation , Tissue Scaffolds
8.
Anticancer Drugs ; 23(8): 803-14, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22361842

ABSTRACT

This study investigated the antineoplasic potential of a new family of aminosteroids. The antiproliferative activity of seven 5α-androstane-3α,17ß-diol derivatives selected from a screening study was measured on nine cancerous cell lines (HL-60, K-562, LNCaP, PC-3, Shionogi, MCF-7, MDA-MB-231, BT-20, and OVCAR-3) and two normal cell lines (peripheral blood lymphocytes and WI-38). The aminosteroids efficiently inhibited the cell growth of seven cancer cell lines [inhibitory concentration (IC(50)) values=0.2-6.4 µmol/l] and showed weak toxicity on normal cell lines. Two representative aminosteroids were tested and found to induce apoptosis and a G0/G1 cell cycle block in HL-60-treated cells, but not terminal myeloid differentiation. By a nuclear morphology analysis with fluorescence microscopy, typical apoptotic morphological changes were exhibited by treated cells. One aminosteroid tested in vivo (xenograft model) reduced the breast cancer (MCF-7 cells) tumor growth induced in nude mice. Furthermore, the information gathered suggests that this family of aminosteroids induced growth inhibition cells by arresting the cell cycle and triggering apoptosis.


Subject(s)
Androstane-3,17-diol/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Neoplasms/drug therapy , Androstane-3,17-diol/chemistry , Animals , Antineoplastic Agents/chemistry , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Cell Line , Cell Line, Tumor , Female , G1 Phase/drug effects , HL-60 Cells , Humans , Inhibitory Concentration 50 , Mice , Mice, Inbred BALB C , Mice, Nude , Microscopy, Fluorescence , Neoplasms/pathology , Resting Phase, Cell Cycle/drug effects , Xenograft Model Antitumor Assays
9.
Pharm Res ; 28(10): 2516-29, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21638135

ABSTRACT

PURPOSE: The efficacy of chemotherapy is decreased due to over-expression of the drug transporter P-glycoprotein (P-gp). This study was conducted to determine the feasibility of down-regulating tumor P-gp levels with non-viral siRNA delivery in order to sensitize the tumors to drug therapy. METHODS: P-gp over-expressing MDA435/LCC6 MDR1 cells were used to establish xenografts in NOD-SCID mouse. Cationic polymers polyethylenimine (PEI) and stearic acid-substituted poly-L-lysine (PLL-StA) were formulated with P-gp- specific siRNAs and delivered intratumorally to explore the feasibility of P-gp down-regulation in tumors. Intravenous Doxil™ was administered to investigate tumor growth. RESULTS: PEI and PLL-StA effectively delivered siRNA to MDA435/LCC6 MDR1 cells in vitro to reduce P-gp expression for 3 days. Intratumoral injection of siRNA with the carriers resulted in 60-80% and 20-32% of siRNA retention in tumors after 24 and 96 hr, respectively. This led to ~29.0% and ~61.5% P-gp down-regulation with PEI- and PLL-StA-mediated siRNA delivery, respectively. The P-gp down-regulation by intratumoral siRNA injection led to better response to systemic Doxil™ treatment, resulting in slowed tumor growth in originally doxorubicin-resistant tumors. CONCLUSION: Effective P-gp down-regulation was feasible with polymeric siRNA delivery in a xenograft model, resulting in an enhanced response to the drug therapy.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily B/genetics , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/genetics , ATP Binding Cassette Transporter, Subfamily B/biosynthesis , Animals , Down-Regulation , Doxorubicin/administration & dosage , Doxorubicin/pharmacokinetics , Drug Carriers/administration & dosage , Drug Delivery Systems/methods , Drug Resistance, Neoplasm , Female , Lysine/administration & dosage , Mice , Mice, Inbred NOD , Mice, SCID , Neoplasms/genetics , Neoplasms/metabolism , Polyethyleneimine/administration & dosage , Polymers/administration & dosage , Stearic Acids/administration & dosage , Tumor Cells, Cultured , Xenograft Model Antitumor Assays/methods
10.
Int Wound J ; 8(3): 280-90, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21401885

ABSTRACT

A complex compound (immune ('IM') fraction) from colostrum-derived whey was investigated for its potential wound healing properties. One of its most intriguing in vitro abilities was to significantly inhibit the contraction of collagen gel while fibroblast density remained as in control gels. This antagonist effect was dose dependent and fibroblasts in these gels did not exhibit any stress fibres. Subsequently, in vivo studies have been conducted in two wound models in guinea pigs. Daily application on full-thickness wounds of a liquid formulation of the IM fraction (first model) significantly delayed wound closure by contraction compared to what normally occurred in control wounds. In another wound model, a gel formulation of the IM fraction was applied on scar tissues, which resulted in a minimised residual scar on 5/8 wounds compared to corresponding wound areas seen prior to treatment. Conversely, most control wounds exhibited scar tissue from which 3/8 resembled hypertrophic scar tissue. Wound tissue treated with IM fraction covered a significantly larger area than in the control wounds, whereas the collagen deposition was unchanged as in the presence of α-smooth muscle actin. Thus, IM fraction may act by modulating the contraction rate and wound remodelling.


Subject(s)
Cicatrix/therapy , Collagen/pharmacology , Fibroblasts/physiology , Wound Healing/physiology , Wounds and Injuries/therapy , Animals , Cicatrix/pathology , Collagen/metabolism , Colostrum/chemistry , Disease Models, Animal , Female , Fibroblasts/drug effects , Guinea Pigs , Random Allocation , Reference Values , Sensitivity and Specificity , Tissue Engineering , Wounds and Injuries/pathology
11.
Macromol Biosci ; 11(1): 13-21, 2011 Jan 10.
Article in English | MEDLINE | ID: mdl-21038349

ABSTRACT

Non-woven polyethylene terephthalate (PET) fibers produced via melt blowing and compounded into a 6 mm diameter 3D tubular scaffold were developed with artery matching mechanical properties. This work compares the effects of ethylene oxide (EtO) and low temperature plasma (LTP) sterilization on PET surface chemistry and biocompatibility. As seen through X-ray photoelectron spectroscopy (XPS) analysis, LTP sterilization led to an increase in overall oxygen content and the creation of new hydroxyl groups. EtO sterilization induced alkylation of the PET polymer. The in vitro cytotoxicity showed similar fibroblastic viability on LTP- and EtO-treated PET fibers. However, TNF-α release levels, indicative of macrophage activation, were significantly higher when macrophages were incubated on EtO-treated PET fibers. Subcutaneous mice implantation revealed an inflammatory response with foreign body reaction to PET grafts independent of the sterilization procedure.


Subject(s)
Blood Vessel Prosthesis , Polyethylene Terephthalates/chemistry , Tissue Scaffolds/chemistry , Animals , Blood Vessel Prosthesis Implantation , Cell Line , Cell Proliferation/drug effects , Cell Survival/drug effects , Ethylene Oxide/chemistry , Foreign-Body Reaction/etiology , Foreign-Body Reaction/pathology , Humans , Macrophage Activation , Materials Testing , Mice , Plasma Gases , Polyethylene Terephthalates/toxicity , Sterilization , Subcutaneous Tissue/pathology , Surface Properties
12.
J Tissue Eng Regen Med ; 4(7): 524-31, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20872739

ABSTRACT

Development of an in vitro prevascularized scaffold is of great importance to produce vascularization in tissue-engineered devices and for other clinical purposes. To this aim, polymer fibres covered with human umbilical vein endothelial cells (HUVECs) were used to induce directional 'angiogenesis' in a 3D co-culture system. Gelatin or RGD peptides were immobilized on surface-modified polymer fibres [100 µm diameter poly(ethylene terephthalate) monofilaments] via N-hepthylamine plasma polymer and carboxy-methyl-dextran interlayers. Fibres fully covered with HUVECs were then embedded in a fibrin gel, following a parallel alignment pattern, in the presence of fibroblasts. Tube-like structures occurred along the fibres and a network was formed between neighbouring fibres. These events were promoted with increased incubation times. Biomolecule-grafted fibres created a guidance pathway that facilitated coated endothelial cells to form lumens and, from them, sprouting processes. However, there were no significant differences between the different surface modifications on fibres in terms of promoting tube-like structures. Thus, different stages of angiogenesis can be initiated and guided using HUVECs precovered polymer fibres embedded in a soft supportive matrix, such as fibrin, which can be further applied to the development of in vitro prevascularized tissue-engineered scaffolds.


Subject(s)
Cell Movement , Dextrans/chemistry , Endothelial Cells/cytology , Fibroblasts/cytology , Neovascularization, Physiologic , Polyethylene Glycols/chemistry , Coculture Techniques , Fibrin/chemistry , Humans , Polyethylene Terephthalates , Umbilical Veins/cytology
14.
Biomaterials ; 31(5): 824-31, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19854506

ABSTRACT

Copper is known to trigger endothelial cells towards angiogenesis. Different approaches have been investigated to develop vascularisation in biomaterials. The angiogenic and healing potential of copper ions in combination with two major angiogenic factors was examined. A 3D culture system in which, under stimulation by FGF-2 and to a lesser degree with VEGF, endothelial cells assembled into structures resembling to an angiogenic process was used. The combination of CuSO(4) with increasing doses of VEGF or FGF-2 enhanced the complexity of angiogenic networks in a significant manner. In vivo studies were also conducted by incorporating FGF-2 with CuSO(4) in a cylindrical collagen-based scaffold. CuSO(4) enhanced significantly the invasion of microvessel compared to control implants and to 20ng FGF-2+/-CuSO(4). Vascular infiltration was also significantly improved by combination of CuSO(4) with FGF-2, compared to FGF-2 alone (0.2 and 1microg). Nevertheless, in comparison with CuSO(4) alone, there was a significant increase only with 1microg of FGF-2 combined with CuSO(4). Significantly, collagen fiber deposition was enhanced following the combinatory loading in comparison to that with FGF-2 alone but not with CuSO(4) only. Thus, copper associated with growth factors may have synergistic effects which are highly attractive in the fields of tissue engineering (e.g., bone) and biomaterials.


Subject(s)
Collagen/administration & dosage , Copper/administration & dosage , Endothelial Cells/drug effects , Endothelial Cells/physiology , Neovascularization, Physiologic/physiology , Tissue Engineering/methods , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemistry , Cell Culture Techniques/methods , Cell Proliferation/drug effects , Cells, Cultured , Collagen/chemistry , Copper/chemistry , Humans , Neovascularization, Physiologic/drug effects
15.
J Biomed Mater Res A ; 93(2): 615-24, 2010 May.
Article in English | MEDLINE | ID: mdl-19591233

ABSTRACT

Among different strategies to provide blood supply to tissue-engineered devices and implants, the use of arteriovenous loops and bundles has been proposed. The aim of this study was to compare the vascularization and healing processes that took place in a one-end closed tubular collagen-based scaffold at different implantation sites in mice. These conditions were in the presence or absence of heparin and/or bone marrow cells. By 30 days, very few cell infiltrations were observed in the dorsal subcutaneous and peritoneal implants at any conditions; however, the presence of heparin and bone marrow cells improved cell infiltration toward an inflammatory reaction. The insertion of an arteriovenous bundle into the central cavity of the scaffold resulted in partial wound tissue infiltration in the control scaffolds implanted subcutaneously in the hind limb. In similar conditions, the presence of bone marrow cells and heparin resulted in dense wound tissue with numerous capillaries and a significant amount of newly deposited collagen fibers. The design of a central cavity in a porous scaffold with one closed end may facilitate invasion from the central part of the implant toward the implant wall. In addition, the presence of both a vascular component and stem/progenitor cells may lead to a vascularized implant while limiting the inflammatory reaction.


Subject(s)
Collagen , Neovascularization, Physiologic/physiology , Tissue Engineering , Tissue Scaffolds/chemistry , Animals , Cattle , Collagen/chemistry , Collagen/metabolism , Humans , Implants, Experimental , Inflammation/metabolism , Inflammation/pathology , Mice , Microvessels/cytology , Microvessels/metabolism , Tissue Culture Techniques/instrumentation , Tissue Culture Techniques/methods , Tissue Engineering/instrumentation , Tissue Engineering/methods
16.
Anticancer Res ; 29(10): 4013-8, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19846944

ABSTRACT

BACKGROUND: Osteoprotegerin (OPG) expression participates in the pathophysiology of osteoblastic metastasis in prostate cancer. MATERIALS AND METHODS: We investigated whether the expression of OPG of PC-3 prostate cancer cells grown in 3-D collagen gels is stimulated by co-culture with MG-63 osteoblast-like cells. The expression of Runx2 (Cbfa1) and OPG were assessed by reverse transcription-polymerase chain reaction and Western blot analysis. RESULTS: OPG and Runx2 were expressed in both PC-3 and MG-63 cells. OPG expression was remarkably enhanced in PC-3 cells grown in co-culture with MG-63 cells in a time-dependent manner. Runx2 expression of PC-3 cells was not altered by their co-culture with MG-63 cells. OPG expression of PC-3 cells was altered neither by insulin-like growth factor I (IGF-1), transforming growth factor beta1 (TGFbeta1), interleukin 6 (IL-6) nor by dexamethasone and zoledronic acid exogenously added to PC-3 cells. CONCLUSION: The enhancement of the OPG expression in PC-3 cells by MG-63 cells is not mediated by IGF-1, IL-6 and TGFbeta1.


Subject(s)
Cell Communication/physiology , Osteoblasts/pathology , Osteoprotegerin/biosynthesis , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Bone Neoplasms/pathology , Bone Neoplasms/secondary , Coculture Techniques , Core Binding Factor Alpha 1 Subunit/biosynthesis , Humans , Insulin-Like Growth Factor I/pharmacology , Interleukin-6/pharmacology , Male , Osteoblasts/metabolism , Osteosarcoma/metabolism , Osteosarcoma/pathology , Transforming Growth Factor beta1/pharmacology
17.
Tissue Eng Part A ; 15(7): 1601-9, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19182977

ABSTRACT

Angiogenesis in a tissue-engineered device may be induced by incorporating growth factors (e.g., vascular endothelial growth factor [VEGF]), genetically modified cells, and=or vascular cells. It represents an important process during the formation and repair of tissue and is essential for nourishment and supply of reparative and immunological cells. Inorganic angiogenic factors, such as copper ions, are therefore of interest in the fields of regenerative medicine and tissue engineering due to their low cost, higher stability, and potentially greater safety compared with recombinant proteins or genetic engineering approaches. The purpose of this study was to compare tissue responses to 3D printed macroporous bioceramic scaffolds implanted in mice that had been loaded with either VEGF or copper sulfate. These factors were spatially localized at the end of a single macropore some 7 mm from the surface of the scaffold. Controls without angiogenic factors exhibited only poor tissue growth within the blocks; in contrast, low doses of copper sulfate led to the formation of microvessels oriented along the macropore axis. Further, wound tissue ingrowth was particularly sensitive to the quantity of copper sulfate and was enhanced at specific concentrations or in combination with VEGF. The potential to accelerate and guide angiogenesis and wound healing by copper ion release without the expense of inductive protein(s) is highly attractive in the area of tissue-engineered bone and offers significant future potential in the field of regenerative biomaterials.


Subject(s)
Calcium Phosphates/pharmacology , Copper/metabolism , Inorganic Chemicals/metabolism , Neovascularization, Physiologic/drug effects , Tissue Scaffolds , Angiogenesis Inducing Agents/pharmacology , Animals , Blood Vessels/drug effects , Blood Vessels/growth & development , Copper Sulfate/pharmacology , Immunohistochemistry , Implants, Experimental , Ions , Mice , Platelet Endothelial Cell Adhesion Molecule-1/immunology , Porosity/drug effects
18.
Genes Dev ; 22(21): 2932-40, 2008 Nov 01.
Article in English | MEDLINE | ID: mdl-18981472

ABSTRACT

Metastasis suppressor genes inhibit one or more steps required for metastasis without affecting primary tumor formation. Due to the complexity of the metastatic process, the development of experimental approaches for identifying genes involved in metastasis prevention has been challenging. Here we describe a genome-wide RNAi screening strategy to identify candidate metastasis suppressor genes. Following expression in weakly metastatic B16-F0 mouse melanoma cells, shRNAs were selected based upon enhanced satellite colony formation in a three-dimensional cell culture system and confirmed in a mouse experimental metastasis assay. Using this approach we discovered 22 genes whose knockdown increased metastasis without affecting primary tumor growth. We focused on one of these genes, Gas1 (Growth arrest-specific 1), because we found that it was substantially down-regulated in highly metastatic B16-F10 melanoma cells, which contributed to the high metastatic potential of this mouse cell line. We further demonstrated that Gas1 has all the expected properties of a melanoma tumor suppressor including: suppression of metastasis in a spontaneous metastasis assay, promotion of apoptosis following dissemination of cells to secondary sites, and frequent down-regulation in human melanoma metastasis-derived cell lines and metastatic tumor samples. Thus, we developed a genome-wide shRNA screening strategy that enables the discovery of new metastasis suppressor genes.


Subject(s)
Cell Cycle Proteins/metabolism , Genes, Tumor Suppressor/physiology , Melanoma/metabolism , Membrane Proteins/metabolism , RNA, Small Interfering/genetics , Animals , Apoptosis , Cell Line, Tumor , GPI-Linked Proteins , Genome , Genome-Wide Association Study , Humans , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Melanoma/secondary , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Melanoma, Experimental/secondary , Mice , Mice, Inbred C57BL , Neoplasm Transplantation , RNA, Neoplasm , Tissue Array Analysis
19.
Acta Biomater ; 4(5): 1315-21, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18486574

ABSTRACT

Brushite-based biomaterials are of special interest in bone regeneration due to their biocompatibility and biodegradability; on the other hand, collagen is a well-known osteoconductive biomaterial. In the present study a new brushite-collagen composite biomaterial is reported. This new biomaterial was prepared by combining citric acid/collagen type I solutions with a brushite cement powder. The obtained biomaterial was a cement paste, with improved handling properties. The effect of collagen on the setting reaction of brushite cement was studied, and was found to speed up the cement setting reaction. The cement paste set into a hard ceramic material within 18.5+/-2.1min and had compressive strength similar to that of spongeous bone (48.9+/-5.9MPa in dry conditions and 12.7+/-1.5MPa in humid conditions). The combination of collagen with citric acid revealed an interesting synergistic effect on the compressive strength of the composite material. Moreover, this new biomaterial had excellent cohesion properties (ninefold better than brushite cement), and high cellular adhesion capacity (threefold higher than brushite cement). The composite biomaterial described in this study combines good handling properties, compressive strength, cohesion and cell adhesion capacity, along with the osteoconductive and biodegradable properties inherent in brushite and in collagen-based biomaterials.


Subject(s)
Bone Cements/chemistry , Bone Regeneration/physiology , Bone Substitutes/chemistry , Calcium Phosphates/chemistry , Cell Adhesion/physiology , Collagen Type I/chemistry , Regeneration/physiology , 3T3 Cells , Animals , Cell Proliferation , Manufactured Materials , Materials Testing , Mice , Osseointegration/physiology
20.
Cancer Lett ; 262(2): 265-75, 2008 Apr 18.
Article in English | MEDLINE | ID: mdl-18234419

ABSTRACT

The protein tyrosine phosphatase (PTP) superfamily of enzymes functions with protein tyrosine kinases to regulate a broad spectrum of fundamental physiological processes. Addition of the PTP inhibitor potassium bisperoxo(1,10-phenanthroline)oxo-vanadate(V) [bpV(phen)] to the culture medium of human ovarian cancer cells (OVCAR-3) resulted in a dose-dependent decrease in the formation of tumors in a 3-D culture system. An evaluation of the potency of bpV(phen) in vivo confirmed the anti-tumor activity. Further study of the mechanism of action revealed a 40% decrease in Cdk2 kinase activity, an elevated level of Cdk2/p27(kip1), and the appearance of Cdk2/SHP-1 complexes. Therefore, a cytostatic dose of a PTP inhibitor increases the intracellular levels of Cdk2/p27(kip) and Cdk2/SHP-1 complexes, which indicate the presence of additional mechanisms underlying the anti-tumor activity.


Subject(s)
Adenocarcinoma/metabolism , Calcium-Binding Proteins/metabolism , Cyclin-Dependent Kinase 2/metabolism , Ovarian Neoplasms/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 6/metabolism , Protein Tyrosine Phosphatases/antagonists & inhibitors , Cell Culture Techniques , Female , Humans , Organometallic Compounds/pharmacology , Phenanthrolines/pharmacology , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...